Main View
This view is used for searching all possible sources.
First Page Previous Page 1 2 3 Next Page Last Page
 
1
Induction and Acceleration of Mammary Tumors by Activated ...
2010-07-01

... Accession Number : ADA541877. Title : Induction and Acceleration of Mammary Tumors by Activated P13 Kinase. Descriptive ...

DTIC Science & Technology

2
Activated type I TGFbeta receptor (Alk5) kinase confers enhancedsurvival to mammary epithelial cells and accelerates mammary tumorprogression
2005-01-02

The transforming growth factor-betas (TGF{beta}s) are members of a large superfamily of pleiotropic cytokines that also includes the activins and the bone morphogenetic proteins (BMPs). Members of the TGF{beta} family regulate complex physiological processes such cell proliferation, differentiation, adhesion, cell-cell and cell-matrix interactions, motility, and cell death, among others (Massague, ...

DOE Information Bridge

3
Do myoepithelial cells hold the key for breast tumorprogression?
2005-11-18

Mammary myoepithelial cells have been the foster child of breast cancer biology and have been largely ignored since they were considered to be less important for tumorigenesis than luminal epithelial cells from which most of breast carcinomas are thought to arise. In recent years as our knowledge in stem cell biology and the cellular microenvironment has been increasing ...

Energy Citations Database

4
Role of Dynein Light Chain 1 in Tamoxifen Resistance in ...
2007-03-01

... mammary neoplasia. Moreover, mammary glands from MMTV-DLC1- Ser88Ala mice had accelerated involution. Together ...

DTIC Science & Technology

5
Characterization of Wnt-1 Transgenic Mice (with and without p53-deficiency) as Models of Spontaneous Mammary Tumorigenesis for Chemoprevention Studies.
1998-01-01

Wnt-1 transgenic(TG) mice develop mammary tumors at a high rate by 1 year of age due to mammary gland overexpression of the Wnt-1 oncogene. - We have shown that p53-deficiency accelerates mammary tumorigenesis in these mice, with 100% of p53-1- Wnt-1 TG m...

National Technical Information Service (NTIS)

6
Characterization of Wnt-1 Transgenic Mice (with and without ...
1997-09-01

... Mammary tumorigenesis is further accelerated in p53-deficient Wnt-1 TG mice generated by mating Wnt-1 TG mice with p53-knockout mice. ...

DTIC Science & Technology

7
Characterization of Wnt-1 Transgenic Mice (with and without p53-deficiency) as Models of Spontaneous Mammary Tumorigenesis for Chemoprevention Studies.
1997-01-01

The ectopic expression of the Wnt-1 proto-oncogene in Wnt-1 transgenic (Wnt-1 TG) mice results in mammary gland hyperplasia and early adenocarcinoma development. Mammary tumorigenesis is further accelerated in p53-deficient Wnt-1 TG mice generated by mati...

National Technical Information Service (NTIS)

8
4-Vinylcyclohexene diepoxide (VCD) inhibits mammary epithelial differentiation and induces fibroadenoma formation in female Sprague Dawley rats.
2011-05-20

4-Vinylcyclohexene diepoxide (VCD), an occupational chemical that targets ovarian follicles and accelerates ovarian failure in rodents, was used to test the effect of early-onset reproductive senescence on mammary fibroadenoma formation. One-month female Sprague Dawley rats were dosed with VCD (80mg/kg or 160mg/kg) and monitored for 22 months for ...

PubMed

9
RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis.
2010-09-29

RANK ligand (RANKL), a TNF-related molecule, is essential for osteoclast formation, function and survival through interaction with its receptor RANK. Mammary glands of RANK- and RANKL-deficient mice develop normally during sexual maturation, but fail to form lobuloalveolar structures during pregnancy because of defective proliferation and increased apoptosis of ...

PubMed

10
Effects of BRCA1 Transgene Expression on Murine Mammary Gland Development and Mutagen-Induced Mammary Neoplasia
2007-04-25

To characterize the role of BRCA1 in mammary gland development and tumor suppression, a transgenic mouse model of BRCA1 overexpression was developed. Using the mouse mammary tumor virus (MMTV) promoter/enhancer, transgenic mice expressing human BRCA1 or select mutant controls were generated. Transgenic animals examined during adolescence were shown to ...

PubMed Central

11
Repressor of Estrogen Receptor Activity (REA) Is Essential for Mammary Gland Morphogenesis and Functional Activities: Studies in Conditional Knockout Mice.
2011-08-23

Estrogen receptor (ER) is a key regulator of mammary gland development and is also implicated in breast tumorigenesis. Because ER-mediated activities depend critically on coregulator partner proteins, we have investigated the consequences of reduction or loss of function of the coregulator repressor of ER activity (REA) by conditionally deleting one allele or both alleles of ...

PubMed

12
The role of neutralizing antibodies for mouse mammary tumor virus transmission and mammary cancer development
2003-01-01

Mouse mammary tumor virus (MMTV) infection establishes chronic germinal centers and a lifelong neutralizing Ab response. We show that removal of the draining lymph node after establishment of the germinal center reaction led to complete loss of neutralizing Abs despite comparable infection levels in peripheral lymphocytes. Importantly, in the absence of neutralization, only ...

NASA Astrophysics Data System (ADS)

13
Growth Factors and Metalloproteinases in Breast Cancer Development and Progression.
1997-01-01

We show that the metalloproteinase matrilysin dramatically accelerates the development of neu-induced mammary tumors by decreasing the time to tumor onset and increasing the percent of animals developing tumors. In addition, MMTV-matrilysin transgenic mic...

National Technical Information Service (NTIS)

14
Experience with High-Energy Electron Beam Therapy at the University of Chicago.
1979-01-01

Current utilization of the linear accelerator as well as 5-year cumulative experience in radiotherapy is presented. Cutaneous lymphomas and mammary gland carcinomas were the prime experience region; however, cancers at other locations were treated with mi...

National Technical Information Service (NTIS)

15
Regression of rat mammary tumors associated with suppressed growth hormone.

Serum growth hormone (GH) was suppressed in female rats bearing mammary tumors induced by 7, 12, dimethylbenz(a)anthracene (DMBA) or N-nitrosomethylurea(NMU). Serum GH was suppressed due to treatment with a human GH analog produced by the plerocercoid stage of the tapeworm Spirometra mansonoides. Rats treated with plerocercoid growth factor (PGF) via plerocercoid infection had ...

PubMed

16
Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors.
2010-03-22

Novel therapeutic agents combined with innovative modes of delivery and non-invasive imaging of drug delivery, pharmacokinetics and efficacy are crucial in developing effective clinical anticancer therapies. In this study, we have created and characterized multiple novel variants of anti-angiogenic protein thrombospondin (aaTSP-1) that comprises unique regions of three type-I-repeats of TSP-1 and ...

PubMed

17
Effects of BRCA1 transgene expression on murine mammary gland development and mutagen-induced mammary neoplasia.
2007-04-25

To characterize the role of BRCA1 in mammary gland development and tumor suppression, a transgenic mouse model of BRCA1 overexpression was developed. Using the mouse mammary tumor virus (MMTV) promoter/enhancer, transgenic mice expressing human BRCA1 or select mutant controls were generated. Transgenic animals examined during adolescence were shown to ...

PubMed

18
Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors
2006-01-23

Epidemiological studies indicate that parity enhances HER2/ErbB2/Neu-induced breast tumorigenesis. Furthermore, recent studies using multiparous, ErbB2/Neu-overexpressing mouse mammary tumor virus (MMTV-Neu) mice have shown that parity induces a population of cells that are targeted for ErbB2/Neu-induced transformation. Although parity accelerates ...

PubMed Central

19
Mammary gland development in transforming growth factor beta1 null mutant mice: systemic and epithelial effects.
2008-07-09

The cytokine-transforming growth factor beta1 (TGFB1) is implicated in development of the mammary gland through regulation of epithelial cell proliferation and differentiation during puberty and pregnancy. We compared mammary gland morphogenesis in virgin Tgfb1(+/+), Tgfb1(+/-), and Tgfb1(-/-) mice and transplanted Tgfb1(+/+) and Tgfb1(-/-) epithelium to ...

PubMed

20
Induction of mammary gland hyperplasia in transgenic mice over-expressing human Cdc25B.
1999-08-12

Cdc25 A and B are dual-specificity phosphatases which have been implicated in neoplastic transformation. Although Cdc25A and Cdc25B have been found to be over-expressed in many cancer cell lines and primary tumors, the physiological roles of Cdc25A and B in vivo are largely undefined. To investigate the roles of these proteins in the oncogenic transformation of the mammary ...

PubMed

First Page Previous Page 1 2 3 Next Page Last Page
 
First Page Previous Page 1 2 3 Next Page Last Page
 
21
Biphasic effect of short-term pregnancy hormone treatment on N-methyl-N-nitrosourea-induced mammary carcinogenesis in young and old rats.

This study examined the development of N-methyl-N-nitrosourea (MNU)-induced mammary carcinomas in young and old female Lewis rats following short-term treatment with estrogen and progesterone to mimic pregnancy. Rats exposed at 4 weeks of age to MNU were treated at 6 weeks of age (early MNU/young E/P treatment) or at 24 weeks of age (early MNU/old E/P treatment) with a 21-day ...

PubMed

22
Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development
2010-06-21

IntroductionBreast cancer is genetically and clinically a heterogeneous disease. However, the exact contribution of different cell types and oncogenic mutations to this heterogeneity are not well understood. Recently, we discovered an interaction between Wnt and integrin-linked kinase (ILK) within the signaling cascade that regulates cell growth and survival. Interestingly, ...

PubMed Central

23
Reduced nursing frequency during prolonged lactation in the mouse decreases milk production and increases mammary expression of tryptophan hydroxylase 1 (TPH1), but does not accelerate mammary gland remodeling

We have observed that lactating mouse dams nursed 4 times per day (4X) maintained lactation, but had lower milk yields by the weigh-suckle-weigh method, than dams nursed ad libitum (AL). Therefore, we hypothesized that decreased nursing frequency would also decrease lactation persistence, increase m...

Technology Transfer Automated Retrieval System (TEKTRAN)

24
NCI Mouse Repository Strain Details

WAPT121 transgenic mice express T121, a trucation mutation of SV40 antigen that binds and inactivates all pRB-related proteins, under control of whey acidic protein (WAP) promoter. T121 expression was detected in the mammary gland (Simin et al., 2004). Transgenic females failed to nurse pups because of lactation defects. Multi-pregnant females developed ...

Cancer.gov

25
The Spy1/RINGO family represents a novel mechanism regulating mammary growth and tumorigenesis.
2008-05-15

Spy1A is a unique cell cycle activator known to mediate cell cycle progression and override the DNA damage response. This study focused on determining the role of this protein on postnatal mammary gland morphogenesis and neoplasia. Herein, we show that Spy1A levels are tightly regulated during mammary gland development and that ectopic expression ...

PubMed

26
PTEN Deficiency in a Luminal ErbB-2 Mouse Model Results in Dramatic Acceleration of Mammary Tumorigenesis and Metastasis*
2009-07-10

Overexpression and/or amplification of the ErbB-2 oncogene as well as inactivation of the PTEN tumor suppressor are two important genetic events in human breast carcinogenesis. To address the biological impact of conditional inactivation of PTEN on ErbB-2-induced mammary tumorigenesis, we generated a novel transgenic mouse model that utilizes the murine ...

PubMed Central

27
Constitutive activation of JAK2 in mammary epithelium elevates Stat5 signalling, promotes alveologenesis and resistance to cell death, and contributes to tumourigenesis.
2011-09-23

Signalling through the janus kinase (JAK)/signal transducer and activator of transcription (Stat) pathway is required at different stages of mammary gland development, and this pathway is frequently hyper-activated in cancer, including tumours of the breast. Stats 3, 5 and 6 have important roles in the differentiation and survival of mammary alveolar ...

PubMed

28
Accelerated apoptosis in the Timp-3�deficient mammary gland
2001-09-15

The proapoptotic proteinase inhibitor TIMP-3 is the only molecule of this family thought to influence cell death. We examined epithelial apoptosis in TIMP-3�deficient mice during mammary gland involution. Lactation was not affected by the absence of TIMP-3, but glandular function, as measured by gland-to-body weight ratio and production of ?-casein, was suppressed earlier ...

PubMed Central

29
Accelerated apoptosis in the Timp-3-deficient mammary gland.
2001-09-01

The proapoptotic proteinase inhibitor TIMP-3 is the only molecule of this family thought to influence cell death. We examined epithelial apoptosis in TIMP-3-deficient mice during mammary gland involution. Lactation was not affected by the absence of TIMP-3, but glandular function, as measured by gland-to-body weight ratio and production of beta-casein, was suppressed earlier ...

PubMed

30
Prepubertal exposure to cow's milk reduces susceptibility to carcinogen-induced mammary tumorigenesis in rats.
2011-01-01

Cow's milk contains high levels of estrogens, progesterone and insulin-like growth factor 1 (IGF-1), all of which are associated with breast cancer. We investigated whether prepubertal milk exposure affects mammary gland development and carcinogenesis in rats. Sprague-Dawley rats were given either whole milk or tap water to drink from postnatal day (PND) 14 to PND 35, and ...

PubMed

31
Endocrine-active chemicals in mammary cancer causation and prevention.
2011-06-23

Endocrine-active chemicals alter or mimic physiological hormones. These compounds are reported to originate from a wide variety of sources, and recent studies have shown widespread human exposure to several of these compounds. Given the role of the sex steroid hormone, estradiol, in human breast cancer causation, endocrine-active chemicals which interfere with estrogen signaling constitute one ...

PubMed

32
Radiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease cancer latency and affect tumor type.
2011-05-17

Tissue microenvironment is an important determinant of carcinogenesis. We demonstrate that ionizing radiation, a known carcinogen, affects cancer frequency and characteristics by acting on the microenvironment. Using a mammary chimera model in which an irradiated host is transplanted with oncogenic Trp53 null epithelium, we show accelerated development of ...

PubMed

33
Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype
2004-06-15

BackgroundMMTV-Wnt1 transgenic mice develop mammary hyperplasia early in development, followed by the appearance of solitary mammary tumors with a high proportion of cells expressing early lineage markers and many myoepithelial cells. The occurrence of tumors is accelerated in experiments that activate FGF proto-oncogenes or remove the ...

PubMed Central

34
Curcumin delays development of MPA-accelerated DMBA-induced mammary tumors
2010-01-01

ObjectiveCombined hormone replacement therapy (HRT) containing estrogen and progestin (medroxyprogesterone acetate [MPA]) leads to increased risk of breast cancer in postmenopausal women, compared with HRT regimens containing estrogen alone, or placebo. We previously reported that, in animal models, progestins can accelerate the development of mammary ...

PubMed Central

35
Transforming Growth Factor-? Regulator SnoN Modulates Mammary Gland Branching Morphogenesis, Postlactational Involution, and Mammary Tumorigenesis
2010-05-11

SnoN is an important negative regulator of transforming growth factor-? (TGF-?) signaling that was originally identified as a transforming oncogene in chicken embryonic fibroblasts. Both pro-oncogenic and antioncogenic activities of SnoN have been reported, but its function in normal epithelial cells has not been defined. In the mouse mammary gland, SnoN is expressed at ...

PubMed Central

36
Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency
2010-08-02

Genetically defined mouse models offer an important tool to identify critical secondary genetic alterations with relevance to human cancer pathogenesis. We used newly generated MMTV-Cre105Ayn mice to inactivate p53 and/or Rb strictly in the mammary epithelium and to determine recurrent genomic changes associated with deficiencies of these genes. p53 inactivation led to ...

PubMed Central

37
PPAR? signaling exacerbates mammary gland tumor development
2004-03-01

Breast cancer cell lines that express the nuclear peroxisome proliferator-activated receptor ? (PPAR?) can be prompted to undergo growth arrest and differentiation when treated with synthetic PPAR? ligands. To evaluate the therapeutic potential of increased PPAR? signaling in vivo, we generated transgenic mice that express a constitutively active form of PPAR? in mammary ...

PubMed Central

38
PPAR gamma signaling exacerbates mammary gland tumor development.
2004-03-01

Breast cancer cell lines that express the nuclear peroxisome proliferator-activated receptor gamma (PPAR gamma) can be prompted to undergo growth arrest and differentiation when treated with synthetic PPAR gamma ligands. To evaluate the therapeutic potential of increased PPAR gamma signaling in vivo, we generated transgenic mice that express a constitutively active form of PPAR gamma in ...

PubMed

39
Influence of chronic prolactin suppression during puberty on the development of dimethylbenz(a)anthracene-induced mammary tumors (41163). [Rats
1981-06-01

In order to assess the effect of early prolactin suppression on the subsequent development of dimethylbenz(a)anthracene (DMBA)-induced mammary cancers, the dopamine agonist, CB-154, was chronically administered to female Sprague-Dawley rats from Day 35 to Day 50 of age. DMBA was then administered and tumor development assessed over a 25-week period. It was found that animals ...

Energy Citations Database

40
Experience with high-energy electron beam therapy at the University of Chicago
1979-01-01

Current utilization of the linear accelerator as well as 5-year cumulative experience in radiotherapy is presented. Cutaneous lymphomas and mammary gland carcinomas were the prime experience region; however, cancers at other locations were treated with mixed-beam therapy; employing fast neutrons and photon beams. The technique appears promising for ...

Energy Citations Database

First Page Previous Page 1 2 3 Next Page Last Page
 
First Page Previous Page 1 2 3 Next Page Last Page
 
41
A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
1999-04-15

Estrogens have important functions in mammary gland development and carcinogenesis. To better define these roles, we have used two previously characterized lines of genetically altered mice: estrogen receptor-alpha (ER alpha) knockout (ERKO) mice, which lack the gene encoding ER alpha, and mouse mammary virus tumor (MMTV)-Wnt-1 transgenic mice (Wnt-1 TG), ...

PubMed

42
p38? Signaling Induces Anoikis and Lumen Formation During Mammary Morphogenesis.
2011-05-24

The stress-activated protein kinase (SAPK) p38 can induce apoptosis, and its inhibition facilitates mammary tumorigenesis. We found that during mammary acinar morphogenesis in MCF-10A cells grown in three-dimensional culture, detachment of luminal cells from the basement membrane stimulated mitogen-activated protein kinase (MAPK) kinases 3 and 6 (MKK3/6) ...

PubMed

43
Apigenin Prevents Development of Medroxyprogesterone Acetate-Accelerated 7,12-Dimethylbenz(a)anthracene-Induced Mammary Tumors in Sprague-Dawley Rats.
2011-04-19

The use of progestins as a component of hormone replacement therapy has been linked to an increase in breast cancer risk in postmenopausal women. We have previously shown that medroxyprogesterone acetate (MPA), a commonly administered synthetic progestin, increases production of the potent angiogenic factor vascular endothelial growth factor (VEGF) by tumor cells, leading to the development of new ...

PubMed

44
USF-1 as an Inhibitor of Mammary Gland Carcinogenesis
2002-09-01

... in these studies is that overexpression of USF in the mammary glands of transgenic ... form or USF-2 was targeted to the mammary gland under the ...

DTIC Science & Technology

45
Training in Mammary Gland Biology and Breast Cancer
2004-09-01

... salivary and mammary glands. ... mechanisms responsible for the initiation of branching, especially in the mammary gland, remain to be determined. ...

DTIC Science & Technology

46
The Role of Myoepithelium in Mammary Development and ...
2001-09-01

... effects of myoepithelial cells on mammary development because the K5 promoter directs transgene expression in mammary glands exclusively to ...

DTIC Science & Technology

47
The Role of B-Catenin in Mammary Gland Development and ...
2002-03-01

... role in mammary gland development and tumorigenesis. Descriptors : *ORGANS(ANATOMY), *MAMMARY GLANDS, *ONCOGENIC VIRUSES ...

DTIC Science & Technology

48
Targeted Retroviral Infection of Mammary Cells in Viral ...
1997-09-01

... receptor for the avian virus Rous sarcoma virus in mammary ... MAMMARY GLANDS, RETROVIRUSES, ONCOGENIC VIRUSES, SARCOMA VIRUS. ...

DTIC Science & Technology

49
Role of the Int-3 Oncogene in Mammary Gland Development ...
1995-09-12

... whether int-3 is expressed in the mammary gland and whether this expression is developmentally regulated. ... neoplastic mammary glands. ...

DTIC Science & Technology

50
Role of Whn in Mammary Gland Development and ...
2002-10-01

... Abstract : The Whn transcription factor plays an essential role in the development and maturation of mammary glands, as mammary glands in the ...

DTIC Science & Technology

51
Protein Kinases in Mammary Gland Development and ...
1997-10-01

... to determine if the expression of the kinases is regulated during mammary gland development, RNA was isolated from mammary glands of FVB ...

DTIC Science & Technology

52
In Utero Exposure to Cadmium, Mammary Gland ...
2008-05-01

... In Utero Exposure to Cadmium, Mammary Gland Development, and Breast Cancer Risk ... the effects of estrogens in the mammary glands and uterus ...

DTIC Science & Technology

53
Hormonal Regulation of Mammary Gland Development and ...
2005-12-01

... TITLE: Hormonal Regulation of Mammary Gland Development and Breast Cancer ... extended for lactating mammary gland tissue. ...

DTIC Science & Technology

54
Hormonal Regulation of Mammary Gland Development and ...
2003-12-01

... and that haploinsufficiency of CBP does not appear to affect mammary gland development. Descriptors : *MAMMARY GLANDS, *BREAST CANCER ...

DTIC Science & Technology

55
ESTABLISHMENT AND CHARACTERIZATION OF A CAPRINE MAMMARY EPITHELIAL CELL LINE (CMEC)

... modulate the development, function, and involution of the mammary gland epithelium. Difficulty in studying the mammary gland is also ... ...

NBII National Biological Information Infrastructure

56
Cloning of Mammary Stem Cells
2001-11-01

... these cells in primary mammary epithelial cell cultures. ... and lobulogenesis (ie these cells have important features of mammary stem cells). ...

DTIC Science & Technology

57
Breast Cancer Prevention by Hormonally Induced Mammary ...
2003-10-01

... Cancer Prevention by Hormonally Induced Mammary Gland Differentiation: The Role of a Novel Mammary Growth Inhibitor and Differentiation ...

DTIC Science & Technology

58
Mice expressing a mammary gland-specific R270H mutation in the p53 tumor suppressor gene mimic human breast cancer development.
2005-09-15

The tumor suppressor gene p53 has an apparent role in breast tumor development in humans, as approximately 30% of sporadic tumors acquire p53 mutations and Li-Fraumeni syndrome patients carrying germ line p53 mutations frequently develop breast tumors at early age. In the present study, conditional expression of a targeted mutation is used to analyze the role of the human R273H tumor-associated ...

PubMed

59
Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ER?-negative and ER?-positive mammary preneoplasia and cancer
2007-07-23

BRCA1 can regulate estrogen receptor-? (ER?) activity. This study tested the hypotheses that Brca1 loss in mammary epithelium alters the estrogenic growth response and that exposure to increased estrogen or ER? collaborates with Brca1 deficiency to accelerate preneoplasia and cancer development. Longer ductal extension was found in ...

PubMed Central

60
Investigation of the Link Between Prolactin, Mammary Gland ...
2002-10-01

... in Prlr(+/-) mammary glands but increased in Elf5(+/-) mammary glands. ... proliferation to differentiation within the mammary gland during pregnancy. ...

DTIC Science & Technology

First Page Previous Page 1 2 3 Next Page Last Page